Երկիր: Իռլանդիա
Լեզու: անգլերեն
Աղբյուրը: HPRA (Health Products Regulatory Authority)
PARACETAMOL
McNeil Healthcare (Ireland) Ltd
N02BE01
PARACETAMOL
120 MG/5ml
Oral Suspension
Product not subject to medical prescription
Analgesics and antipyretics
Authorised
1993-04-01
Package leaflet: Information for the user _120 mg/5 ml_ _INFANT ORAL SUSPENSION_ _Contains Paracetamol_ Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. ■ Keep this leaflet. You may need to read it again. ■ Ask your pharmacist if you need more information or advice. ■ If your child gets any side-effects, talk to your doctor or pharmacist. This includes any possible side-effects not listed in this leaflet. See section 4. ■ You must talk to a doctor if your child does not feel better or feels worse after 3 days. What is in this leaflet 1. What Calpol is and what it is used for 2. What you need to know before you use Calpol 3. How to take Calpol 4. Possible side-effects 5. How to store Calpol 6. Contents of the pack and other information 1 What Calpol is and what it is used for The paracetamol in Calpol Infant Oral Suspension is used to relieve pain such as tooth pain, headache, sore throat and aches and pains that come with colds and flu. It also brings down fever (high temperature). 2 What you need to know before you use Calpol Do not give your child this medicine… ■ If s/he is allergic to paracetamol or any of the other ingredients of this medicine (listed in section 6). ■ If s/he is taking anything else with paracetamol in it. ■ If s/he weighs less than 4 kg. If any of these applies, get advice from a doctor or pharmacist without using Calpol. Warnings and precautions Talk to your doctor or pharmacist… ■ If your child has serious kidney or liver problems. ■ If your child has an inherited intolerance to fructose or been diagnosed with an intolerance to some other sugars. Other medicines and Calpol Tell your doctor or pharmacist if your child is taking any other medicines including: ■ _metoclopramide_ or _domperidone_ (used to treat nausea and vomiting) ■ _colestyramine_ (used to treat high cholesterol) ■ Կարդացեք ամբողջական փաստաթուղթը
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Calpol 120 mg/5 ml Infant Oral Suspension. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Calpol Infant Oral Suspension contains - Excipients with known effect (per 5ml): Sucrose 2202.48mg Sorbitol Liquid (E420) 451.5mg Methyl parahydroxybenzoate (E218) 5.0mg Propyl parahydroxybenzoate (E216) 1.0mg Ethyl parahydroxybenzoate (E214) 2.0mg Carmoisine (E122) 0.075mg For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral suspension. A viscous pink coloured suspension with a strawberry odour and taste. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Calpol Infant Suspension is indicated for the treatment of pain (including teething pain), and as an antipyretic. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION INFANTS AGED 2-3 MONTHS: Paracetamol 120 mg per 5 ml. AGE : 2 – 3 MONTHS DOSE 1. POST-VACCINATION FEVER 2.5 ml If necessary, after 4-6 hours, give a second 2.5 ml dose 2. OTHER CAUSES OF PAIN AND FEVER - if your baby weighs over 4 kg and was born after 37 weeks Do not give to babies less than 2 months of age. Do not give more than 2 doses unless your doctor or nurse has advised otherwise. Leave at least 4 hours between doses. If further doses are needed, talk to your doctor or pharmacist. It is important to SHAKE THE BOTTLE for at least 10 seconds before use. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _3_ _/_ _0_ _3_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _2_ _1_ _8_ _9_ _4_ _3_ _0_ _p_ _a_ _g_ _ Կարդացեք ամբողջական փաստաթուղթը